ABT · Abbott Laboratories
United States · RS rating 60 · As of 2026-10-14
| Price | 102.97 USD |
|---|---|
| 1-day change | +0.3% |
| RS rating (overall / 1M / 3M / 12M) | 60 / 76 / 79 / 26 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 31 / 35 / 17 |
| Industry group (rank) | Medical-Diversified (32) |
| EPS growth Q/Q | +7.5% |
| Sales growth Q/Q | +0.8% |
| Distance from 52-week high | +22.7% |
| Market cap (USD) | $160.7B |